Otonomy Suspends Development of Lead Drug After Phase III Flop, Stock Plunges Post author:Sam Post published:August 29, 2017 Post category:BioPharma August 30, 2017By Alex Keown, BioSpace… Source: BioSpace You Might Also Like FUJIFILM Release: FDA Approves The Company's Digital Breast Tomosynthesis Option For ASPIRE Cristalle Digital Mammography System January 23, 2017 Vertex Quietly Terminates a Small Phase II CF Trial September 11, 2017 Apotex CEO Abruptly Resigns Amid Allegations of Trade Secret Leaks January 28, 2018
FUJIFILM Release: FDA Approves The Company's Digital Breast Tomosynthesis Option For ASPIRE Cristalle Digital Mammography System January 23, 2017
